Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have received a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $13.50.

Several equities research analysts have issued reports on OSCR shares. Raymond James started coverage on shares of Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target on the stock. The Goldman Sachs Group boosted their price target on shares of Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a report on Friday, February 9th. TheStreet raised shares of Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Finally, Wells Fargo & Company upped their target price on shares of Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th.

Institutional Trading of Oscar Health

A number of hedge funds have recently modified their holdings of the company. Southeastern Asset Management Inc. TN raised its position in shares of Oscar Health by 30.8% in the 4th quarter. Southeastern Asset Management Inc. TN now owns 14,576,904 shares of the company’s stock valued at $35,859,000 after acquiring an additional 3,430,032 shares during the period. Vanguard Group Inc. increased its stake in Oscar Health by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 14,244,912 shares of the company’s stock worth $130,341,000 after purchasing an additional 116,978 shares in the last quarter. BlackRock Inc. increased its stake in Oscar Health by 10.3% during the 2nd quarter. BlackRock Inc. now owns 12,397,356 shares of the company’s stock worth $99,923,000 after purchasing an additional 1,155,528 shares in the last quarter. Formation8 GP LLC bought a new stake in Oscar Health during the 4th quarter worth approximately $47,480,000. Finally, State Street Corp increased its stake in Oscar Health by 12.7% during the 2nd quarter. State Street Corp now owns 3,207,395 shares of the company’s stock worth $25,852,000 after purchasing an additional 361,233 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Performance

Shares of OSCR opened at $15.68 on Friday. Oscar Health has a one year low of $4.72 and a one year high of $18.55. The company has a 50-day moving average of $15.25 and a two-hundred day moving average of $10.68. The stock has a market cap of $3.60 billion, a price-to-earnings ratio of -13.07 and a beta of 1.79. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.19 and a quick ratio of 1.19.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.08. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company’s revenue was up 43.9% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.05) earnings per share. On average, equities research analysts expect that Oscar Health will post -0.23 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.